nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—Ibuprofen—Melphalan—ovarian cancer	0.426	1	CrCrCtD
Atenolol—ABCB1—ovarian cancer	0.323	1	CbGaD
Atenolol—ABCB1—Topotecan—ovarian cancer	0.0458	0.354	CbGbCtD
Atenolol—ABCB1—Vinorelbine—ovarian cancer	0.0322	0.249	CbGbCtD
Atenolol—ABCB1—Paclitaxel—ovarian cancer	0.0226	0.175	CbGbCtD
Atenolol—ABCB1—Docetaxel—ovarian cancer	0.0164	0.127	CbGbCtD
Atenolol—ABCB1—Doxorubicin—ovarian cancer	0.0122	0.0945	CbGbCtD
Atenolol—Procarbazine—CYP1B1—ovarian cancer	0.00248	0.679	CrCbGaD
Atenolol—Ibuprofen—CXCL8—ovarian cancer	0.000486	0.133	CrCbGaD
Atenolol—Acebutolol—ABCB1—ovarian cancer	0.000249	0.0683	CrCbGaD
Atenolol—Myocardial infarction—Docetaxel—ovarian cancer	0.000215	0.00183	CcSEcCtD
Atenolol—Vascular purpura—Epirubicin—ovarian cancer	0.000214	0.00183	CcSEcCtD
Atenolol—Decreased appetite—Vinorelbine—ovarian cancer	0.000213	0.00182	CcSEcCtD
Atenolol—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000212	0.0018	CcSEcCtD
Atenolol—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000212	0.0018	CcSEcCtD
Atenolol—Fatigue—Vinorelbine—ovarian cancer	0.000211	0.0018	CcSEcCtD
Atenolol—Metoprolol—ABCB1—ovarian cancer	0.000211	0.0576	CrCbGaD
Atenolol—Pain—Vinorelbine—ovarian cancer	0.00021	0.00179	CcSEcCtD
Atenolol—Constipation—Vinorelbine—ovarian cancer	0.00021	0.00179	CcSEcCtD
Atenolol—Arrhythmia—Paclitaxel—ovarian cancer	0.000207	0.00177	CcSEcCtD
Atenolol—Epistaxis—Docetaxel—ovarian cancer	0.000207	0.00176	CcSEcCtD
Atenolol—Asthenia—Topotecan—ovarian cancer	0.000206	0.00175	CcSEcCtD
Atenolol—Alopecia—Paclitaxel—ovarian cancer	0.000205	0.00175	CcSEcCtD
Atenolol—Hot flush—Epirubicin—ovarian cancer	0.000205	0.00175	CcSEcCtD
Atenolol—Agranulocytosis—Docetaxel—ovarian cancer	0.000205	0.00174	CcSEcCtD
Atenolol—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000203	0.00173	CcSEcCtD
Atenolol—Menopausal symptoms—Epirubicin—ovarian cancer	0.000203	0.00173	CcSEcCtD
Atenolol—Pruritus—Topotecan—ovarian cancer	0.000203	0.00173	CcSEcCtD
Atenolol—Feeling abnormal—Vinorelbine—ovarian cancer	0.000202	0.00172	CcSEcCtD
Atenolol—Asthenia—Melphalan—ovarian cancer	0.000201	0.00172	CcSEcCtD
Atenolol—Purpura—Epirubicin—ovarian cancer	0.000199	0.0017	CcSEcCtD
Atenolol—Pruritus—Melphalan—ovarian cancer	0.000199	0.00169	CcSEcCtD
Atenolol—Vascular purpura—Doxorubicin—ovarian cancer	0.000198	0.00169	CcSEcCtD
Atenolol—Tension—Paclitaxel—ovarian cancer	0.000198	0.00169	CcSEcCtD
Atenolol—Cardiac failure—Epirubicin—ovarian cancer	0.000197	0.00168	CcSEcCtD
Atenolol—Nervousness—Paclitaxel—ovarian cancer	0.000196	0.00167	CcSEcCtD
Atenolol—Diarrhoea—Topotecan—ovarian cancer	0.000196	0.00167	CcSEcCtD
Atenolol—Lethargy—Epirubicin—ovarian cancer	0.000196	0.00167	CcSEcCtD
Atenolol—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000196	0.00167	CcSEcCtD
Atenolol—Body temperature increased—Vinorelbine—ovarian cancer	0.000194	0.00165	CcSEcCtD
Atenolol—Diarrhoea—Melphalan—ovarian cancer	0.000192	0.00164	CcSEcCtD
Atenolol—Pain in extremity—Epirubicin—ovarian cancer	0.000192	0.00164	CcSEcCtD
Atenolol—Nausea—Chlorambucil—ovarian cancer	0.000191	0.00163	CcSEcCtD
Atenolol—Vision blurred—Paclitaxel—ovarian cancer	0.00019	0.00162	CcSEcCtD
Atenolol—Hot flush—Doxorubicin—ovarian cancer	0.00019	0.00162	CcSEcCtD
Atenolol—Visual impairment—Docetaxel—ovarian cancer	0.00019	0.00162	CcSEcCtD
Atenolol—Dizziness—Topotecan—ovarian cancer	0.00019	0.00162	CcSEcCtD
Atenolol—Affect lability—Epirubicin—ovarian cancer	0.000189	0.00161	CcSEcCtD
Atenolol—Menopausal symptoms—Doxorubicin—ovarian cancer	0.000188	0.0016	CcSEcCtD
Atenolol—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000188	0.0016	CcSEcCtD
Atenolol—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000188	0.0016	CcSEcCtD
Atenolol—Purpura—Doxorubicin—ovarian cancer	0.000184	0.00157	CcSEcCtD
Atenolol—Flushing—Docetaxel—ovarian cancer	0.000183	0.00156	CcSEcCtD
Atenolol—Cardiac arrest—Epirubicin—ovarian cancer	0.000182	0.00155	CcSEcCtD
Atenolol—Malaise—Paclitaxel—ovarian cancer	0.000182	0.00155	CcSEcCtD
Atenolol—Cardiac failure—Doxorubicin—ovarian cancer	0.000182	0.00155	CcSEcCtD
Atenolol—Mood swings—Epirubicin—ovarian cancer	0.000182	0.00155	CcSEcCtD
Atenolol—Vertigo—Paclitaxel—ovarian cancer	0.000182	0.00155	CcSEcCtD
Atenolol—Syncope—Paclitaxel—ovarian cancer	0.000181	0.00154	CcSEcCtD
Atenolol—Lethargy—Doxorubicin—ovarian cancer	0.000181	0.00154	CcSEcCtD
Atenolol—Rash—Topotecan—ovarian cancer	0.000181	0.00154	CcSEcCtD
Atenolol—Dermatitis—Topotecan—ovarian cancer	0.000181	0.00154	CcSEcCtD
Atenolol—Ataxia—Epirubicin—ovarian cancer	0.00018	0.00154	CcSEcCtD
Atenolol—Headache—Topotecan—ovarian cancer	0.00018	0.00153	CcSEcCtD
Atenolol—Palpitations—Paclitaxel—ovarian cancer	0.000179	0.00152	CcSEcCtD
Atenolol—Loss of consciousness—Paclitaxel—ovarian cancer	0.000178	0.00151	CcSEcCtD
Atenolol—Pain in extremity—Doxorubicin—ovarian cancer	0.000178	0.00151	CcSEcCtD
Atenolol—Rash—Melphalan—ovarian cancer	0.000177	0.00151	CcSEcCtD
Atenolol—Dermatitis—Melphalan—ovarian cancer	0.000177	0.00151	CcSEcCtD
Atenolol—Cough—Paclitaxel—ovarian cancer	0.000176	0.0015	CcSEcCtD
Atenolol—Asthenia—Vinorelbine—ovarian cancer	0.000176	0.0015	CcSEcCtD
Atenolol—Arrhythmia—Docetaxel—ovarian cancer	0.000176	0.0015	CcSEcCtD
Atenolol—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000175	0.00149	CcSEcCtD
Atenolol—Affect lability—Doxorubicin—ovarian cancer	0.000175	0.00149	CcSEcCtD
Atenolol—Alopecia—Docetaxel—ovarian cancer	0.000174	0.00148	CcSEcCtD
Atenolol—Pruritus—Vinorelbine—ovarian cancer	0.000173	0.00148	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000173	0.00147	CcSEcCtD
Atenolol—Chest pain—Paclitaxel—ovarian cancer	0.000172	0.00147	CcSEcCtD
Atenolol—Anxiety—Paclitaxel—ovarian cancer	0.000171	0.00146	CcSEcCtD
Atenolol—Nausea—Topotecan—ovarian cancer	0.00017	0.00145	CcSEcCtD
Atenolol—Discomfort—Paclitaxel—ovarian cancer	0.00017	0.00145	CcSEcCtD
Atenolol—Cardiac arrest—Doxorubicin—ovarian cancer	0.000169	0.00144	CcSEcCtD
Atenolol—Dry mouth—Paclitaxel—ovarian cancer	0.000168	0.00143	CcSEcCtD
Atenolol—Mood swings—Doxorubicin—ovarian cancer	0.000168	0.00143	CcSEcCtD
Atenolol—Diarrhoea—Vinorelbine—ovarian cancer	0.000168	0.00143	CcSEcCtD
Atenolol—Ataxia—Doxorubicin—ovarian cancer	0.000167	0.00142	CcSEcCtD
Atenolol—Nausea—Melphalan—ovarian cancer	0.000167	0.00142	CcSEcCtD
Atenolol—Confusional state—Paclitaxel—ovarian cancer	0.000166	0.00142	CcSEcCtD
Atenolol—Oedema—Paclitaxel—ovarian cancer	0.000165	0.00141	CcSEcCtD
Atenolol—Shock—Paclitaxel—ovarian cancer	0.000162	0.00138	CcSEcCtD
Atenolol—Dizziness—Vinorelbine—ovarian cancer	0.000162	0.00138	CcSEcCtD
Atenolol—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000162	0.00138	CcSEcCtD
Atenolol—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000161	0.00138	CcSEcCtD
Atenolol—Tachycardia—Paclitaxel—ovarian cancer	0.000161	0.00137	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00016	0.00136	CcSEcCtD
Atenolol—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000159	0.00136	CcSEcCtD
Atenolol—Anorexia—Paclitaxel—ovarian cancer	0.000157	0.00134	CcSEcCtD
Atenolol—Rash—Vinorelbine—ovarian cancer	0.000155	0.00132	CcSEcCtD
Atenolol—Dermatitis—Vinorelbine—ovarian cancer	0.000154	0.00132	CcSEcCtD
Atenolol—Hypotension—Paclitaxel—ovarian cancer	0.000154	0.00131	CcSEcCtD
Atenolol—Headache—Vinorelbine—ovarian cancer	0.000154	0.00131	CcSEcCtD
Atenolol—Syncope—Docetaxel—ovarian cancer	0.000154	0.00131	CcSEcCtD
Atenolol—Palpitations—Docetaxel—ovarian cancer	0.000151	0.00129	CcSEcCtD
Atenolol—Loss of consciousness—Docetaxel—ovarian cancer	0.000151	0.00128	CcSEcCtD
Atenolol—Cough—Docetaxel—ovarian cancer	0.000149	0.00127	CcSEcCtD
Atenolol—Insomnia—Paclitaxel—ovarian cancer	0.000149	0.00127	CcSEcCtD
Atenolol—Paraesthesia—Paclitaxel—ovarian cancer	0.000148	0.00126	CcSEcCtD
Atenolol—Drowsiness—Epirubicin—ovarian cancer	0.000148	0.00126	CcSEcCtD
Atenolol—Dyspnoea—Paclitaxel—ovarian cancer	0.000147	0.00125	CcSEcCtD
Atenolol—Somnolence—Paclitaxel—ovarian cancer	0.000147	0.00125	CcSEcCtD
Atenolol—Chest pain—Docetaxel—ovarian cancer	0.000146	0.00124	CcSEcCtD
Atenolol—Nausea—Vinorelbine—ovarian cancer	0.000146	0.00124	CcSEcCtD
Atenolol—Renal failure—Epirubicin—ovarian cancer	0.000145	0.00124	CcSEcCtD
Atenolol—Dyspepsia—Paclitaxel—ovarian cancer	0.000145	0.00124	CcSEcCtD
Atenolol—Decreased appetite—Paclitaxel—ovarian cancer	0.000143	0.00122	CcSEcCtD
Atenolol—Dry mouth—Docetaxel—ovarian cancer	0.000143	0.00122	CcSEcCtD
Atenolol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000142	0.00121	CcSEcCtD
Atenolol—Fatigue—Paclitaxel—ovarian cancer	0.000142	0.00121	CcSEcCtD
Atenolol—Sweating—Epirubicin—ovarian cancer	0.000142	0.00121	CcSEcCtD
Atenolol—Pain—Paclitaxel—ovarian cancer	0.000141	0.0012	CcSEcCtD
Atenolol—Constipation—Paclitaxel—ovarian cancer	0.000141	0.0012	CcSEcCtD
Atenolol—Confusional state—Docetaxel—ovarian cancer	0.000141	0.0012	CcSEcCtD
Atenolol—Oedema—Docetaxel—ovarian cancer	0.00014	0.00119	CcSEcCtD
Atenolol—Epistaxis—Epirubicin—ovarian cancer	0.000139	0.00119	CcSEcCtD
Atenolol—Agranulocytosis—Epirubicin—ovarian cancer	0.000138	0.00118	CcSEcCtD
Atenolol—Shock—Docetaxel—ovarian cancer	0.000138	0.00117	CcSEcCtD
Atenolol—Thrombocytopenia—Docetaxel—ovarian cancer	0.000137	0.00117	CcSEcCtD
Atenolol—Drowsiness—Doxorubicin—ovarian cancer	0.000137	0.00117	CcSEcCtD
Atenolol—Tachycardia—Docetaxel—ovarian cancer	0.000136	0.00116	CcSEcCtD
Atenolol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000136	0.00116	CcSEcCtD
Atenolol—Bradycardia—Epirubicin—ovarian cancer	0.000135	0.00115	CcSEcCtD
Atenolol—Renal failure—Doxorubicin—ovarian cancer	0.000134	0.00115	CcSEcCtD
Atenolol—Anorexia—Docetaxel—ovarian cancer	0.000133	0.00114	CcSEcCtD
Atenolol—Sweating—Doxorubicin—ovarian cancer	0.000131	0.00112	CcSEcCtD
Atenolol—Hypotension—Docetaxel—ovarian cancer	0.000131	0.00111	CcSEcCtD
Atenolol—Body temperature increased—Paclitaxel—ovarian cancer	0.00013	0.00111	CcSEcCtD
Atenolol—Epistaxis—Doxorubicin—ovarian cancer	0.000129	0.0011	CcSEcCtD
Atenolol—Visual impairment—Epirubicin—ovarian cancer	0.000128	0.00109	CcSEcCtD
Atenolol—Agranulocytosis—Doxorubicin—ovarian cancer	0.000128	0.00109	CcSEcCtD
Atenolol—Insomnia—Docetaxel—ovarian cancer	0.000126	0.00108	CcSEcCtD
Atenolol—Paraesthesia—Docetaxel—ovarian cancer	0.000126	0.00107	CcSEcCtD
Atenolol—Bradycardia—Doxorubicin—ovarian cancer	0.000125	0.00107	CcSEcCtD
Atenolol—Dyspnoea—Docetaxel—ovarian cancer	0.000125	0.00106	CcSEcCtD
Atenolol—Somnolence—Docetaxel—ovarian cancer	0.000124	0.00106	CcSEcCtD
Atenolol—Tinnitus—Epirubicin—ovarian cancer	0.000124	0.00105	CcSEcCtD
Atenolol—Flushing—Epirubicin—ovarian cancer	0.000123	0.00105	CcSEcCtD
Atenolol—Dyspepsia—Docetaxel—ovarian cancer	0.000123	0.00105	CcSEcCtD
Atenolol—Decreased appetite—Docetaxel—ovarian cancer	0.000122	0.00104	CcSEcCtD
Atenolol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000121	0.00103	CcSEcCtD
Atenolol—Ibuprofen—ABCB1—ovarian cancer	0.000121	0.033	CrCbGaD
Atenolol—Fatigue—Docetaxel—ovarian cancer	0.000121	0.00103	CcSEcCtD
Atenolol—Pain—Docetaxel—ovarian cancer	0.00012	0.00102	CcSEcCtD
Atenolol—Constipation—Docetaxel—ovarian cancer	0.00012	0.00102	CcSEcCtD
Atenolol—Arrhythmia—Epirubicin—ovarian cancer	0.000119	0.00101	CcSEcCtD
Atenolol—Visual impairment—Doxorubicin—ovarian cancer	0.000118	0.00101	CcSEcCtD
Atenolol—Asthenia—Paclitaxel—ovarian cancer	0.000118	0.00101	CcSEcCtD
Atenolol—Alopecia—Epirubicin—ovarian cancer	0.000117	0.001	CcSEcCtD
Atenolol—Pruritus—Paclitaxel—ovarian cancer	0.000117	0.000995	CcSEcCtD
Atenolol—Feeling abnormal—Docetaxel—ovarian cancer	0.000115	0.000982	CcSEcCtD
Atenolol—Tinnitus—Doxorubicin—ovarian cancer	0.000115	0.000976	CcSEcCtD
Atenolol—Flushing—Doxorubicin—ovarian cancer	0.000114	0.000971	CcSEcCtD
Atenolol—Tension—Epirubicin—ovarian cancer	0.000113	0.000966	CcSEcCtD
Atenolol—Diarrhoea—Paclitaxel—ovarian cancer	0.000113	0.000962	CcSEcCtD
Atenolol—Nervousness—Epirubicin—ovarian cancer	0.000112	0.000956	CcSEcCtD
Atenolol—Body temperature increased—Docetaxel—ovarian cancer	0.000111	0.000942	CcSEcCtD
Atenolol—Arrhythmia—Doxorubicin—ovarian cancer	0.00011	0.000935	CcSEcCtD
Atenolol—Dizziness—Paclitaxel—ovarian cancer	0.000109	0.00093	CcSEcCtD
Atenolol—Vision blurred—Epirubicin—ovarian cancer	0.000109	0.000928	CcSEcCtD
Atenolol—Alopecia—Doxorubicin—ovarian cancer	0.000109	0.000925	CcSEcCtD
Atenolol—Ill-defined disorder—Epirubicin—ovarian cancer	0.000107	0.000914	CcSEcCtD
Atenolol—Propranolol—ABCB1—ovarian cancer	0.000106	0.0291	CrCbGaD
Atenolol—Tension—Doxorubicin—ovarian cancer	0.000105	0.000894	CcSEcCtD
Atenolol—Malaise—Epirubicin—ovarian cancer	0.000104	0.000888	CcSEcCtD
Atenolol—Rash—Paclitaxel—ovarian cancer	0.000104	0.000886	CcSEcCtD
Atenolol—Dermatitis—Paclitaxel—ovarian cancer	0.000104	0.000885	CcSEcCtD
Atenolol—Nervousness—Doxorubicin—ovarian cancer	0.000104	0.000885	CcSEcCtD
Atenolol—Vertigo—Epirubicin—ovarian cancer	0.000104	0.000885	CcSEcCtD
Atenolol—Syncope—Epirubicin—ovarian cancer	0.000104	0.000883	CcSEcCtD
Atenolol—Headache—Paclitaxel—ovarian cancer	0.000103	0.000881	CcSEcCtD
Atenolol—Palpitations—Epirubicin—ovarian cancer	0.000102	0.00087	CcSEcCtD
Atenolol—Loss of consciousness—Epirubicin—ovarian cancer	0.000102	0.000865	CcSEcCtD
Atenolol—Cough—Epirubicin—ovarian cancer	0.000101	0.000859	CcSEcCtD
Atenolol—Vision blurred—Doxorubicin—ovarian cancer	0.000101	0.000859	CcSEcCtD
Atenolol—Asthenia—Docetaxel—ovarian cancer	0.0001	0.000855	CcSEcCtD
Atenolol—Ill-defined disorder—Doxorubicin—ovarian cancer	9.92e-05	0.000845	CcSEcCtD
Atenolol—Pruritus—Docetaxel—ovarian cancer	9.89e-05	0.000843	CcSEcCtD
Atenolol—Chest pain—Epirubicin—ovarian cancer	9.84e-05	0.000838	CcSEcCtD
Atenolol—Anxiety—Epirubicin—ovarian cancer	9.8e-05	0.000835	CcSEcCtD
Atenolol—Nausea—Paclitaxel—ovarian cancer	9.8e-05	0.000835	CcSEcCtD
Atenolol—Discomfort—Epirubicin—ovarian cancer	9.72e-05	0.000828	CcSEcCtD
Atenolol—Malaise—Doxorubicin—ovarian cancer	9.64e-05	0.000822	CcSEcCtD
Atenolol—Dry mouth—Epirubicin—ovarian cancer	9.62e-05	0.00082	CcSEcCtD
Atenolol—Vertigo—Doxorubicin—ovarian cancer	9.61e-05	0.000819	CcSEcCtD
Atenolol—Syncope—Doxorubicin—ovarian cancer	9.59e-05	0.000817	CcSEcCtD
Atenolol—Diarrhoea—Docetaxel—ovarian cancer	9.57e-05	0.000815	CcSEcCtD
Atenolol—Confusional state—Epirubicin—ovarian cancer	9.51e-05	0.00081	CcSEcCtD
Atenolol—Palpitations—Doxorubicin—ovarian cancer	9.45e-05	0.000805	CcSEcCtD
Atenolol—Oedema—Epirubicin—ovarian cancer	9.43e-05	0.000804	CcSEcCtD
Atenolol—Loss of consciousness—Doxorubicin—ovarian cancer	9.4e-05	0.000801	CcSEcCtD
Atenolol—Cough—Doxorubicin—ovarian cancer	9.33e-05	0.000795	CcSEcCtD
Atenolol—Shock—Epirubicin—ovarian cancer	9.28e-05	0.000791	CcSEcCtD
Atenolol—Dizziness—Docetaxel—ovarian cancer	9.25e-05	0.000788	CcSEcCtD
Atenolol—Thrombocytopenia—Epirubicin—ovarian cancer	9.23e-05	0.000787	CcSEcCtD
Atenolol—Tachycardia—Epirubicin—ovarian cancer	9.2e-05	0.000784	CcSEcCtD
Atenolol—Hyperhidrosis—Epirubicin—ovarian cancer	9.12e-05	0.000777	CcSEcCtD
Atenolol—Chest pain—Doxorubicin—ovarian cancer	9.1e-05	0.000776	CcSEcCtD
Atenolol—Anxiety—Doxorubicin—ovarian cancer	9.07e-05	0.000773	CcSEcCtD
Atenolol—Discomfort—Doxorubicin—ovarian cancer	8.99e-05	0.000766	CcSEcCtD
Atenolol—Anorexia—Epirubicin—ovarian cancer	8.99e-05	0.000766	CcSEcCtD
Atenolol—Dry mouth—Doxorubicin—ovarian cancer	8.9e-05	0.000759	CcSEcCtD
Atenolol—Rash—Docetaxel—ovarian cancer	8.82e-05	0.000751	CcSEcCtD
Atenolol—Hypotension—Epirubicin—ovarian cancer	8.81e-05	0.000751	CcSEcCtD
Atenolol—Dermatitis—Docetaxel—ovarian cancer	8.81e-05	0.000751	CcSEcCtD
Atenolol—Confusional state—Doxorubicin—ovarian cancer	8.8e-05	0.00075	CcSEcCtD
Atenolol—Headache—Docetaxel—ovarian cancer	8.76e-05	0.000746	CcSEcCtD
Atenolol—Oedema—Doxorubicin—ovarian cancer	8.73e-05	0.000744	CcSEcCtD
Atenolol—Shock—Doxorubicin—ovarian cancer	8.58e-05	0.000732	CcSEcCtD
Atenolol—Thrombocytopenia—Doxorubicin—ovarian cancer	8.54e-05	0.000728	CcSEcCtD
Atenolol—Insomnia—Epirubicin—ovarian cancer	8.53e-05	0.000727	CcSEcCtD
Atenolol—Tachycardia—Doxorubicin—ovarian cancer	8.52e-05	0.000726	CcSEcCtD
Atenolol—Paraesthesia—Epirubicin—ovarian cancer	8.47e-05	0.000722	CcSEcCtD
Atenolol—Hyperhidrosis—Doxorubicin—ovarian cancer	8.44e-05	0.000719	CcSEcCtD
Atenolol—Dyspnoea—Epirubicin—ovarian cancer	8.41e-05	0.000716	CcSEcCtD
Atenolol—Somnolence—Epirubicin—ovarian cancer	8.38e-05	0.000714	CcSEcCtD
Atenolol—Anorexia—Doxorubicin—ovarian cancer	8.32e-05	0.000709	CcSEcCtD
Atenolol—Nausea—Docetaxel—ovarian cancer	8.3e-05	0.000708	CcSEcCtD
Atenolol—Dyspepsia—Epirubicin—ovarian cancer	8.3e-05	0.000707	CcSEcCtD
Atenolol—Decreased appetite—Epirubicin—ovarian cancer	8.2e-05	0.000699	CcSEcCtD
Atenolol—Hypotension—Doxorubicin—ovarian cancer	8.15e-05	0.000695	CcSEcCtD
Atenolol—Gastrointestinal disorder—Epirubicin—ovarian cancer	8.14e-05	0.000694	CcSEcCtD
Atenolol—Fatigue—Epirubicin—ovarian cancer	8.13e-05	0.000693	CcSEcCtD
Atenolol—Pain—Epirubicin—ovarian cancer	8.06e-05	0.000687	CcSEcCtD
Atenolol—Constipation—Epirubicin—ovarian cancer	8.06e-05	0.000687	CcSEcCtD
Atenolol—Insomnia—Doxorubicin—ovarian cancer	7.89e-05	0.000673	CcSEcCtD
Atenolol—Paraesthesia—Doxorubicin—ovarian cancer	7.83e-05	0.000668	CcSEcCtD
Atenolol—Dyspnoea—Doxorubicin—ovarian cancer	7.78e-05	0.000663	CcSEcCtD
Atenolol—Feeling abnormal—Epirubicin—ovarian cancer	7.77e-05	0.000662	CcSEcCtD
Atenolol—Somnolence—Doxorubicin—ovarian cancer	7.76e-05	0.000661	CcSEcCtD
Atenolol—Dyspepsia—Doxorubicin—ovarian cancer	7.68e-05	0.000655	CcSEcCtD
Atenolol—Decreased appetite—Doxorubicin—ovarian cancer	7.58e-05	0.000646	CcSEcCtD
Atenolol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	7.53e-05	0.000642	CcSEcCtD
Atenolol—Fatigue—Doxorubicin—ovarian cancer	7.52e-05	0.000641	CcSEcCtD
Atenolol—Pain—Doxorubicin—ovarian cancer	7.46e-05	0.000636	CcSEcCtD
Atenolol—Constipation—Doxorubicin—ovarian cancer	7.46e-05	0.000636	CcSEcCtD
Atenolol—Body temperature increased—Epirubicin—ovarian cancer	7.45e-05	0.000635	CcSEcCtD
Atenolol—Feeling abnormal—Doxorubicin—ovarian cancer	7.19e-05	0.000613	CcSEcCtD
Atenolol—Body temperature increased—Doxorubicin—ovarian cancer	6.9e-05	0.000588	CcSEcCtD
Atenolol—Asthenia—Epirubicin—ovarian cancer	6.77e-05	0.000577	CcSEcCtD
Atenolol—Pruritus—Epirubicin—ovarian cancer	6.67e-05	0.000569	CcSEcCtD
Atenolol—Diarrhoea—Epirubicin—ovarian cancer	6.45e-05	0.00055	CcSEcCtD
Atenolol—Asthenia—Doxorubicin—ovarian cancer	6.26e-05	0.000534	CcSEcCtD
Atenolol—Dizziness—Epirubicin—ovarian cancer	6.24e-05	0.000531	CcSEcCtD
Atenolol—Pruritus—Doxorubicin—ovarian cancer	6.17e-05	0.000526	CcSEcCtD
Atenolol—Diarrhoea—Doxorubicin—ovarian cancer	5.97e-05	0.000509	CcSEcCtD
Atenolol—Rash—Epirubicin—ovarian cancer	5.95e-05	0.000507	CcSEcCtD
Atenolol—Dermatitis—Epirubicin—ovarian cancer	5.94e-05	0.000506	CcSEcCtD
Atenolol—Headache—Epirubicin—ovarian cancer	5.91e-05	0.000503	CcSEcCtD
Atenolol—Dizziness—Doxorubicin—ovarian cancer	5.77e-05	0.000492	CcSEcCtD
Atenolol—Nausea—Epirubicin—ovarian cancer	5.6e-05	0.000477	CcSEcCtD
Atenolol—Rash—Doxorubicin—ovarian cancer	5.5e-05	0.000469	CcSEcCtD
Atenolol—Dermatitis—Doxorubicin—ovarian cancer	5.5e-05	0.000468	CcSEcCtD
Atenolol—Headache—Doxorubicin—ovarian cancer	5.47e-05	0.000466	CcSEcCtD
Atenolol—Nausea—Doxorubicin—ovarian cancer	5.18e-05	0.000442	CcSEcCtD
